Calendar
Calendar
From Imaging-to-Omics: a preclinical validation framework for advanced CNS therapeutics in Multiple Sclerosis
PhD defence Leonardo Ricciardi - Department of Biomedical Sciences
Development of biochemical assays to enable FAP-targeted inhibitor discovery and cancer biomarker applications
Public defence Emile Verhulst - Department Pharmaceutical Sciences
Structural and functional insights into the Leishmania donovani dynamin-1-like protein as a promising drug target
Public defence Ellen Wuyts - Department Pharmaceutical Sciences
Bridging antileishmanial drug discovery and cell biology: from mode of action studies to targeting intracellular trafficking
PhD defence Rokaya Abdel-Naiem - Department of Biomedical Sciencs